March 28, 2025 - 01:17

In a significant restructuring move, the U.S. Department of Health and Human Services has announced plans to eliminate approximately 10,000 full-time positions. This decision comes as part of a broader strategy to streamline operations and improve efficiency within the department. Alongside the job cuts, the department will also be closing half of its regional offices, a move that is expected to have a considerable impact on local health services.
The department aims to focus its resources more effectively, responding to the evolving needs of public health in the country. Officials have indicated that these changes are necessary to adapt to fiscal constraints and to enhance the overall effectiveness of health programs.
While the announcement has raised concerns about the potential impact on public health services, the department assures that it will continue to prioritize essential health initiatives. Stakeholders are closely monitoring the situation as the transition unfolds, anticipating both challenges and opportunities in the wake of these significant changes.
May 9, 2026 - 22:43
College of Pharmacy & Health Sciences confers 206 degrees - NewsThe Campbell University College of Pharmacy & Health Sciences held its spring commencement ceremony to honor the achievements of the Class of 2026. A total of 206 degrees were conferred during the...
May 9, 2026 - 02:40
California Becomes First State to Offer Free Diapers for Every NewbornCalifornia is set to launch a first-of-its-kind program that will provide free diapers to every newborn in the state. The initiative, which makes California the first state in the country to offer...
May 8, 2026 - 11:45
Maryland ranked high among states for public health preparedness, but could be doing moreMaryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...
May 7, 2026 - 18:47
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo NordiskThe arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....